Quantessence Capital’s Target TGT Stock Holding History

Quantessence Capital’s Portfolio TGT Stock Details TGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,967	Closed	-$360K	–	125
2026 Q1	$360K	Buy	+2,967	New	+$335K	1.75%	25

Other funds holding TGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantessence Capital's TGT Position: Q2 2026 in Review

Quantessence Capital sold out of Target (TGT) in Q2 2026, closing a stake of 2,967 shares — an estimated $360K sold.

Quantessence Capital first reported a position in TGT in Q1 2026 and held it in 1 quarter. The position peaked at $360K in Q1 2026. 1,887 funds tracked by Wall St. Rank hold TGT as of Q2 2026.

Quantessence Capital reported no remaining Target position as of Q2 2026 after selling out during the quarter.
Quantessence Capital sold 2,967 Target shares in Q2 2026, an estimated $360K.
Quantessence Capital first reported a position in Target in Q1 2026 and held it in 1 quarter.
Quantessence Capital's Target position peaked at $360K in Q1 2026.
1,887 funds tracked by Wall St. Rank held Target as of Q2 2026.

Based on Quantessence Capital's 13F filing for Q2 2026, filed 14 Aug 2026.